Results 31 to 40 of about 53,292,385 (218)

Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: A multicenter study

open access: yesJoint Bone Spine, 2023
Neuropsychiatric (NP) involvement is a restricted area in juvenile-onset systemic lupus erythematosus (jSLE).To investigate the prevalence, demographic and clinical features, and outcomes of the neurological involvement in the Turkish jSLE population.This study was based upon 24 referral centers' SLE cohorts, multicenter and multidisciplinary network ...
Poyrazoğlu, Muammer H   +59 more
openaire   +12 more sources

Belimumab : a technological advance for systemic lupus erythematosus patients? Report of a systematic review and meta-analysis [PDF]

open access: yes, 2013
Objectives: To undertake a systematic review and meta-analysis to investigate clinical effectiveness of belimumab for patients with systemic lupus erythematosus (SLE) and antinuclear and/or anti-double-stranded DNA (dsDNA) autoantibodies.
Hartley, Louise   +17 more
core   +1 more source

Transition Readiness in Adolescents With Juvenile Idiopathic Arthritis and Childhood‐Onset Systemic Lupus Erythematosus

open access: yesACR Open Rheumatology, 2021
Objective The transition from pediatric to adult rheumatology care represents a particularly vulnerable time for patients with juvenile idiopathic arthritis (JIA) and childhood‐onset systemic lupus erythematosus (cSLE).
Jeanine McColl   +11 more
doaj   +1 more source

ICF Core Sets: how to specify impairment and function in systemic lupus erythematosus [PDF]

open access: yes, 2006
The World Health Organization’s International Classification of Function (ICF) is a tool to characterize and illuminate better the full of array of problems a patient faces when affected by disease.
Pisetsky, D.S.   +7 more
core   +1 more source

The Swiss Systemic lupus erythematosus Cohort Study (SSCS) - cross-sectional analysis of clinical characteristics and treatments across different medical disciplines in Switzerland [PDF]

open access: yes, 2014
OBJECTIVES: To describe disease characteristics and treatment modalities in a multidisciplinary cohort of systemic lupus erythematosus (SLE) patients in Switzerland.
Stoll, T.   +48 more
core   +1 more source

Association between academic performance and cognitive dysfunction in patients with juvenile systemic lupus erythematosus

open access: yesRevista Brasileira de Reumatologia, 2016
Objective To determine whether there is an association between the profile of cognitive dysfunction and academic outcomes in patients with juvenile systemic lupus erythematosus (JSLE).
Renan Bazuco Frittoli   +5 more
doaj   +1 more source

Belimumab in a Patient with Systemic Lupus Erythematosus with Juvenile Onset and Steroid-induced Diabetes: Clinical Case

open access: yesВопросы современной педиатрии, 2023
Background. The management of children with systemic lupus erythematosus (SLE) is usually associated with lifelong systemic glucocorticoids administration and, thereby, high risk of serious side effects, including steroid-induced diabetes. The belimumab (
Maria I. Kaleda   +2 more
doaj   +1 more source

Mucocutaneous manifestations in juvenile-onset systemic lupus erythematosus: a review of literature [PDF]

open access: yesPediatric Rheumatology, 2015
Patients diagnosed with juvenile-onset systemic lupus erythematosus (JSLE) often have skin and oral lesions as part of their presentation. These mucocutaneous lesions, as defined by the American College of Rheumatology (ACR) in 1997, include malar rash, discoid rash, photosensitivity and oral ulcers. It is therefore essential to recognize mucocutaneous
Chiewchengchol, Direkrit   +3 more
openaire   +2 more sources

The VH gene repertoire of splenic B cells and somatic hypermutation in systemic lupus erythematosus [PDF]

open access: yes, 2003
In systemic lupus erythematosus (SLE) it has been hypothesized that self-reactive B cells arise from virgin B cells that express low-affinity, nonpathogenic germline V genes that are cross-reactive for self and microbial antigens, which convert to high ...
Stott, DI   +11 more
core   +1 more source

Off-label use of tocilizumab to treat non-juvenile idiopathic arthritis in pediatric rheumatic patients: a literature review

open access: yesPediatric Rheumatology Online Journal, 2018
Tocilizumab, an anti-interleukin-6 (IL-6) agent, is indicated as a treatment for several autoimmune or inflammatory diseases, including rheumatoid arthritis and juvenile idiopathic arthritis (JIA). IL-6 plays roles in both immune system dysregulation and
Ju-Yang Jung   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy